Salesforce (CRM) Stock Forecast & Price Target

$286.26 +5.64 (+2.01%)

Closing price 03:59 PM Eastern

Extended Trading

$285.57 -0.69 (-0.24%)

As of 07:59 PM Eastern

Salesforce - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 42 Analyst Ratings

Sell
1

Hold
5

Buy
36

Based on 42 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 42 analysts, 1 has given a sell rating, 5 have given a hold rating, 31 have given a buy rating, and 5 have given a strong buy rating for CRM.

Consensus Price Target

$362.74
26.71% Upside

According to the 42 analysts' twelve-month price targets for Salesforce, the average price target is $362.74. The highest price target for CRM is $450.00, while the lowest price target for CRM is $236.00. The average price target represents a forecasted upside of 26.71% from the current price of $286.26.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

CRM Analyst Ratings Over Time

Type	Current Forecast 3/24/24 to 3/24/25	1 Month Ago 2/23/24 to 2/22/25	3 Months Ago 12/25/23 to 12/24/24	1 Year Ago 3/25/23 to 3/24/24
Strong Buy	5 Strong Buy rating(s)	4 Strong Buy rating(s)	4 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	31 Buy rating(s)	31 Buy rating(s)	29 Buy rating(s)	23 Buy rating(s)
Hold	5 Hold rating(s)	6 Hold rating(s)	8 Hold rating(s)	9 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$362.74	$375.53	$378.86	$304.32
Forecasted Upside	26.71% Upside	21.32% Upside	10.00% Upside	-1.12% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Remove Ads

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.95	2.69	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	27.70% Upside	629.61% Upside	17.22% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/20/2025	Macquarie 1 of 5 stars	C. Beynon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$320.00 ➝ $320.00	+14.67%
3/19/2025	BMO Capital Markets 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform
3/19/2025	Piper Sandler 2 of 5 stars	B. Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
3/19/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy
3/19/2025	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$311.00	+11.48%
3/17/2025	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Sector Outperform ➝ Sector Outperform	$400.00 ➝ $345.00	+23.43%
2/27/2025	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yun Kim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$330.00 ➝ $300.00	+0.80%
2/27/2025	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$415.00 ➝ $400.00	+34.40%
2/27/2025	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$300.00 ➝ $275.00	-8.98%
2/27/2025	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Difucci Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell ➝ Sell	$247.00 ➝ $247.00	-18.53%
Get the Latest News and Ratings for CRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Salesforce and its competitors with MarketBeat's FREE daily newsletter.
2/27/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$425.00 ➝ $375.00	+24.79%
2/27/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$430.00 ➝ $400.00	+30.21%
2/27/2025	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$400.00 ➝ $400.00	+30.21%
2/27/2025	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$415.00 ➝ $380.00	+23.70%
2/27/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$345.00 ➝ $310.00	+0.91%
2/27/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$440.00 ➝ $400.00	+30.21%
2/19/2025	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	O. Sheikh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
1/17/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Derrick Wood Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$380.00 ➝ $400.00	+24.62%
12/18/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Outperform ➝ Market Outperform	$450.00 ➝ $450.00	+27.15%
12/18/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$425.00 ➝ $425.00	+21.08%
12/13/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ader Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Weight ➝ Overweight	$440.00	+22.84%
12/4/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$340.00 ➝ $380.00	+3.28%
12/4/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$400.00 ➝ $425.00	+15.51%
12/4/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$300.00 ➝ $420.00	+16.53%
12/4/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$360.00 ➝ $400.00	+8.54%
12/4/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$380.00 ➝ $400.00	+20.57%
12/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$415.00 ➝ $425.00	+28.10%
12/4/2024	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$400.00 ➝ $440.00	+32.62%
12/4/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$330.00 ➝ $405.00	+22.07%
11/22/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$275.00 ➝ $360.00	+5.26%
11/19/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
10/17/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aaron Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$343.00	+16.88%
10/2/2024	Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Chokshi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/30/2024	Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Accumulate	$305.00	+20.72%
8/29/2024	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seyrafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Slowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$234.00 ➝ $236.00	-8.87%
8/29/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$335.00 ➝ $335.00	+28.58%
8/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Strong-Buy ➝ Strong-Buy	$325.00 ➝ $350.00	+35.19%
8/26/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$300.00 ➝ $300.00	+13.39%
Most gold “analysts” aren’t really gold analysts… [watch out] (Ad) People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. Go here to learn about my Top Four picks for the coming bull mania.
5/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$350.00 ➝ $300.00	+39.82%
5/30/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$345.00 ➝ $300.00	+10.25%
4/16/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$365.00	+33.82%
3/6/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$290.00 ➝ $354.00	+16.46%
9/15/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$267.00	+22.04%
6/1/2023	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Baldry Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
6/1/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:33 AM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, March 23, 2025. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

The current stock price is $281.56, which may present a buying opportunity for investors looking for growth potential as the company continues to innovate in the CRM space.
Salesforce, Inc. has a strong market capitalization of $270.58 billion, indicating a robust financial position and the ability to invest in future growth initiatives.
Analysts have a consensus rating of "Moderate Buy" with an average target price of $362.74, suggesting that there is potential for stock appreciation based on future performance expectations.
The company has a low debt-to-equity ratio of 0.14, which indicates a conservative approach to leveraging and a lower risk profile for investors.
Salesforce, Inc. is recognized for its advancements in AI technology, positioning itself as a leader in the CRM market with long-term growth potential.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

Insider selling has been significant, with over 60,256 shares sold recently, which may indicate a lack of confidence among executives regarding the company's short-term performance.
The stock has experienced volatility, with a 1-year low of $212.00 and a high of $369.00, suggesting potential risks associated with price fluctuations.
Despite a strong market position, the company has a high price-to-earnings (P/E) ratio of 46.31, which may indicate that the stock is overvalued compared to its earnings.
Recent downgrades from some analysts, such as DA Davidson reducing their price objective to $275.00, could signal caution for potential investors.
Insiders currently own only 3.20% of the company's stock, which may raise concerns about alignment between management and shareholder interests.

CRM Forecast - Frequently Asked Questions

: According to the research reports of 42 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $362.74, with a high forecast of $450.00 and a low forecast of $236.00.
: 42 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last year. There is currently 1 sell rating, 5 hold ratings, 31 buy ratings and 5 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRM shares.
: According to analysts, Salesforce's stock has a predicted upside of 26.71% based on their 12-month stock forecasts.
: Over the previous 90 days, Salesforce's stock had 2 upgrades and 1 downgrade by analysts.
: Salesforce has been rated by research analysts at Bank of America, BMO Capital Markets, Canaccord Genuity Group, Citigroup, DA Davidson, Guggenheim, Loop Capital, Macquarie, Needham & Company LLC, Oppenheimer, Piper Sandler, Redburn Atlantic, Robert W. Baird, Scotiabank, Stephens, Stifel Nicolaus, TD Cowen, and Wells Fargo & Company in the past 90 days.
: Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.95 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CRM) was last updated on 3/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target